Search results
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer...
KAMR Amarillo· 7 days agoThe only solution for intractable cancer caused by mutations in the p53 genePlanning clinical trials targeting cancer patients with no available treatment due to p53 gene mutationsSEOUL, South ...
Malaria No More Commends the U.S. President's Malaria Initiative on Progress in the Face of...
CBS 47 Fresno· 7 days agoAs we celebrate World Malaria Day 2024, Malaria No More commends the incredible progress made by the U.S. President's Malaria Initiative (PMI), as outlined in its newly released 18th Annual ...
HC Wainwright Reaffirms “Buy” Rating for Purple Biotech (NASDAQ:PPBT)
ETF DAILY NEWS· 3 days agoHC Wainwright reaffirmed their buy rating on shares of Purple Biotech (NASDAQ:PPBT – Free Report) in a report issued on Friday, Benzinga reports. HC Wainwright currently has a $10.00 price target ...